Clinical Trial

HUC-MSC for Treatment of High-risk HPV Infection

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated September 24, 2024 (before its estimated September 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the safety and initial effectiveness of human umbilical cord mesenchymal stem cells in HPV clearance.
Trial Details
NCT Number NCT06610773
Lead Sponsor Shanghai East Hospital
Conditions Human Papillomavirus Viruses, Mesenchymal Stem Cells
Enrollment 60 participants
Start Date 2024-03-01
Primary Completion 2025-09-10 (estimated)
Study Completion 2026-09-10 (estimated)
Updated on ClinicalTrials.gov 2024-09-24